Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Persaud

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Journal of Virological Methods|July 19, 2014
Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutationsGillian M Hunt, Lynn Morris, Anitha Moorthy, et al.
The Journal of Infectious Diseases|May 16, 2018
Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected InfantsWei Li A Koay, Jane C Lindsey, Priyanka Uprety, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2015
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected InfantsPriyanka Uprety, Ellen G Chadwick, Kaitlin Rainwater-Lovett, et al.
The New England Journal of Medicine|October 25, 2013
Absence of detectable HIV-1 viremia after treatment cessation in an infantDeborah Persaud, Hannah Gay, Carrie Ziemniak, et al.
AIDS (London, England)|September 16, 2011
Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoirDeborah Persaud, Katherine Luzuriaga, Carrie Ziemniak, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 21, 2023
Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremiaAnna Maya Powell, Deborah Persaud, Jean Rene Anderson, et al.
Current HIV/AIDS Reports|May 2, 2020
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional CureStella J Berendam, Ashley N Nelson, Ria Goswami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapyRichard E Nettles, Tara L Kieffer, Rachel P Simmons, et al.
AIDS (London, England)|October 17, 2018
Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youthZabrina L Brumme, Hanwei Sudderuddin, Carrie Ziemniak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 30, 2021
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trialsLaura Powell, Adit Dhummakupt, Lilly Siems, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Journal of Virological Methods|July 19, 2014
Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutationsGillian M Hunt, Lynn Morris, Anitha Moorthy, et al.
The Journal of Infectious Diseases|May 16, 2018
Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected InfantsWei Li A Koay, Jane C Lindsey, Priyanka Uprety, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2015
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected InfantsPriyanka Uprety, Ellen G Chadwick, Kaitlin Rainwater-Lovett, et al.
The New England Journal of Medicine|October 25, 2013
Absence of detectable HIV-1 viremia after treatment cessation in an infantDeborah Persaud, Hannah Gay, Carrie Ziemniak, et al.
AIDS (London, England)|September 16, 2011
Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoirDeborah Persaud, Katherine Luzuriaga, Carrie Ziemniak, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 21, 2023
Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremiaAnna Maya Powell, Deborah Persaud, Jean Rene Anderson, et al.
Current HIV/AIDS Reports|May 2, 2020
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional CureStella J Berendam, Ashley N Nelson, Ria Goswami, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapyRichard E Nettles, Tara L Kieffer, Rachel P Simmons, et al.
AIDS (London, England)|October 17, 2018
Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youthZabrina L Brumme, Hanwei Sudderuddin, Carrie Ziemniak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 30, 2021
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trialsLaura Powell, Adit Dhummakupt, Lilly Siems, et al.
Pageof 9